NCT01215890View on ClinicalTrials.gov

Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Crohn's DiseaseLow Bone Mineral Density
Interventions
DRUG

risedronate

DRUG

placebo

Trial Locations (1)

T6G-2X8

Gastrointestinal and Liver Disease Research (GILDR) Group, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER